van Lint, Jette A. http://orcid.org/0000-0003-2303-6199
Jessurun, Naomi T. http://orcid.org/0000-0002-8267-1259
Hebing, Renske C. F.
Hoentjen, Frank
Tas, Sander W.
Vonkeman, Harald E.
van Doorn, Martijn B. A.
Sobels, Annemieke
Spuls, Phyllis I. http://orcid.org/0000-0002-6035-2863
van Puijenbroek, Eugene P.
Nurmohamed, Michael T.
van den Bemt, Bart J. F. http://orcid.org/0000-0002-8560-9514
Funding for this research was provided by:
ZonMw (848050005)
Article History
First Online: 25 May 2020
Compliance with Ethical Standards
:
: The <i>Dutch Biologic Monitor</i> work was supported by the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 848050005]. No funding was received for this study.
: JA van Lint, NT Jessurun, RCF Hebing, SW Tas, HE Vonkeman, A Sobels, EP van Puijenbroek, MT Nurmohamed and BJF van den Bemt declare that they have no conflicts of interest. PI Spuls reports unpaid consultancies for Sanofi and Abbvie in the past, a departmental independent research grant for the TREAT NL registry from Leopharma, financial compensation from pharmaceutical industries to her department/hospital for involvement in performing clinical trials and she is chief investigator in the Netherlands national systemic and phototherapy atopic eczema registry (TREAT NL). MBA van Doorn reports grants from Novartis; consulting fees or honorarium from Leopharma, Novartis, Abbvie, BMS, Celgene, Janssen-Cilag, Lily, MSD, Pfizer and Sanofi-Genzyme; support for travel, manuscript preparation or other purposes from Sanofi-Genzyme, Novartis and Pfizer; payment for lectures from Leopharma, Novartis, Janssen-Cilag and Pfizer, all outside the submitted work. F Hoentjen reports received grants, consulting fees or honorarium and payment for lectures, all outside the submitted work.
: Ethical approval was waived for the Dutch Medical Research Involving Human Subjects Act (WMO) by the Medical Research Ethical Committee of Brabant, the Netherlands (file number: NW2016-66). The <i>Dutch Biologic Monitor</i> was approved by the medical ethics committees of the participating hospitals. All participants received information about the <i>Dutch Biologic Monitor</i> prior to participation and signed a digital informed consent form.
: The dataset analysed during the current study is available from the corresponding author on reasonable request.